ArticleTherapeutic advances in medical oncology2019

High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy.

I-Ping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.